Enalare therapeautics, INC.: repurposing drugs in response to chemical threats (REDIRECT) ENA-001
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50121C00044
- Awardee
-
Enalare Therapeutics Inc. UEI MDJFW877BCV6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $749,000
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $749,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $749,000 |
About this award
Enalare Therapeutics Inc. was awarded a $749,000 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract is being performed in Princeton, New Jersey through November 2022 to support the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002 initiative. Under Special Instructions 019 of the announcement, Enalare will pursue the development of host-directed therapeutic candidates to aid long-term outcomes from lung injury. The company will conduct safety review through Phase I and share data and commercialization plans for candidates identified under Area of Interest 12, which focuses on mitigating long-term effects of respiratory distress. No subcontractors or set aside designations were indicated.
Quick answers
Who was awarded contract 75A50121C00044?
75A50121C00044 was awarded to Enalare Therapeutics Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on April 26, 2021.
How much is contract 75A50121C00044 worth?
The government has obligated $749,000 on 75A50121C00044.
Was contract 75A50121C00044 competed?
The extent of competition for 75A50121C00044 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award